InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Kwan Rudolf, Vice-Président Exécutif, Médecin en Chef. Officer active across 1 company, notably Athenex, Inc.. In total, 34 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €14k. Activity tracked since 7 May 2021. The latest transaction was filed on 5 May 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations34 total
3,603 shares@ US$1.361.3% of flowCommon StockSEC:0001209191-23-027948:0
3,755 shares@ US$1.3051.3% of flowCommon StockSEC:0001209191-23-025403:0
4,017 shares@ US$1.221.3% of flowCommon StockSEC:0001209191-23-024010:0
3,525 shares@ US$1.391.3% of flowCommon StockSEC:0001209191-23-021230:0
2,526 shares@ US$1.941.4% of flowCommon StockSEC:0001209191-23-018198:0
1,788 shares@ US$2.741.4% of flowCommon StockSEC:0001209191-23-013263:0
21,778 shares@ US$0.2251.4% of flowCommon StockSEC:0001209191-23-008761:0
25,323 shares@ US$0.19351.3% of flowCommon StockSEC:0001209191-23-005616:0
26,344 shares@ US$0.1861.3% of flowCommon StockSEC:0001209191-23-003394:0
33,220 shares@ US$0.14751.4% of flowCommon StockSEC:0001209191-23-000007:0
41,386 shares@ US$0.11841.4% of flowCommon StockSEC:0001209191-22-062083:0
24,623 shares@ US$0.1991.4% of flowCommon StockSEC:0001209191-22-059991:0
25,257 shares@ US$0.1941.4% of flowCommon StockSEC:0001209191-22-058130:0
25,103 shares@ US$0.19521.5% of flowCommon StockSEC:0001209191-22-056041:0
26,923 shares@ US$0.1821.5% of flowCommon StockSEC:0001209191-22-054402:0
20,340 shares@ US$0.24091.5% of flowCommon StockSEC:0001209191-22-053411:0
20,333 shares@ US$0.2411.5% of flowCommon StockSEC:0001209191-22-051361:0
10,572 shares@ US$0.46351.4% of flowCommon StockSEC:0001209191-22-049558:0
10,346 shares@ US$0.47361.5% of flowCommon StockSEC:0001209191-22-047858:0
17,500 sharesCommon StockSEC:0001209191-22-045863:0
9,665 shares@ US$0.5071.4% of flowCommon StockSEC:0001209191-22-043664:0
8,256 shares@ US$0.59351.4% of flowCommon StockSEC:0001209191-22-042435:0
11,316 shares@ US$0.4331.4% of flowCommon StockSEC:0001209191-22-040594:0
24,832 shares@ US$0.48814.9% of flowCommon StockSEC:0001209191-22-038387:0
9,927 shares@ US$0.49361.9% of flowCommon StockSEC:0001209191-22-034502:0
25 of 34 declarations
About Kwan Rudolf
Kwan Rudolf serves as Executive Vice President and Chief Medical Officer at Athenex, Inc. In this role, he oversees the company's medical and clinical initiatives, focusing on innovation in treatment development. His medical and scientific expertise enables him to lead critical research projects and collaborate with multidisciplinary teams. Kwan Rudolf is committed to advancing Athenex's mission of improving patient care.
